Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives

Phytochemistry Reviews

Volumn 13, Issue 4, 2014, Pages 793-810

  Parikh, Nisha R ^a   Mandal, Animesh ^b   Bhatia, Deepak ^b   Siveen, Kodappully Sivaraman ^c   Sethi, Gautam ^c   Bishayee, Anupam ^a  

^a American University of Health Sciences   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chemoprevention; Mammary cancer; Oleanolic acid; Synthetic oleananes; Treatment

Indexed keywords

6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; ACHYRANTHES FAURIEL EXTRACT; ACHYRANTHOSIDE H; AMOORANIN; AMOORANIN METHYL; BARDOXOLONE; BARDOXOLONE METHYL; BETA AMYRIN; CALENDULA OFFICINALIS EXTRACT; CASPASE 3; CASPASE 9; ERYTHRODIOL; GLEDITSIA SINENSIS EXTRACT; GLOSSOGYNE TENUIFOLIA EXTRACT; HEDERA COLCHICA EXTRACT; HEDERACOLCHISID A; HIBISCUS SYRIACUS EXTRACT; MASLINIC ACID; OLDENLANDIA DIFFUSA EXTRACT; OLEANANE DERIVATIVE; OLEANOLIC ACID; OLEANOLIC ACID DERIVATIVE; PHYSENA MADAGASCARIENSIS EXTRACT; PLACEBO; PLANT EXTRACT; REMANGILONE A; REMANGILONE C; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG; WRIGHTIA TOMENTOSA EXTRACT;

ACHYRANTHES FAURIEL; ACUTE GRANULOCYTIC LEUKEMIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAPLASTIC THYROID CANCER; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARALIACEAE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTERACEAE; BLADDER CANCER; BREAST CANCER; CALENDULA OFFICINALIS; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CAPPARACEAE; CELL PROLIFERATION; CHEMICAL MODIFICATION; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; COLORECTAL CANCER; CONTINUOUS INFUSION; CYTOSOL; DISEASE MODEL; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME RELEASE; FABACEAE; GLEDITSIA SINENSIS; GLOMERULUS FILTRATION RATE; GLOSSOGYNE TENUIFOLIA; HEDERA COLCHICA; HIBISCUS SYRIACUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KIDNEY CANCER; MALVACEAE; MEDICAL RESEARCH; MEDICINAL PLANT; MELANOMA; MOLECULAR MECHANICS; MUCOSA INFLAMMATION; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; MUSCLE SPASM; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OLDENLANDIA DIFFUSA; OLEACEAE; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSENA MADAGASCARIENSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RUBIACEAE; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOEMBOLISM; UTERUS CANCER; WRIGHTIA TOMENTOSA;

EID: 84912031698     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-014-9337-5     Document Type: Review

References (126)

1. Ahmad R, Raina D, Meyer C, Kufe D (2008) Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1) → signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3. Cancer Res 68:2920–2926
2. Aiyer HS, Warri AM, Woode DR, Hilakivi-Clarke L, Clarke R (2012) Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention. J Agric Food Chem 60:5693–5708
3. Allouche Y, Warleta F, Campos M, Sánchez-Quesada C, Uceda M, Beltrán G, Gaforio JJ (2011) Antioxidant, antiproliferative, and pro-apoptotic capacities of pentacyclic triterpenes found in the skin of olives on MCF-7 human breast cancer cells and their effects on DNA damage. J Agric Food Chem 59:121–130
4. American Cancer Society (2013) Retrieved from http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-key-statistics. Accessed 8 Oct 2013
5. Barile E, Fattorusso E, Ialenti A, Ianaro A, Lanzotti V (2007) Paraliane and pepluane diterpenes as anti-inflammatory agents: first insights in structure-activity relationships. Bioorg Med Chem Lett 17:4196–4200
6. Barile E, Borriello M, Di Pietro A, Doreau A, Fattorusso C, Fattorusso E, Lanzotti V (2008) Discovery of a new series of jatrophane and lathyrane diterpenes as potent and specific P-glycoprotein modulators. Org Biomol Chem 6:1756–1762
7. Barthomeuf C, Debiton E, Mshvildadze V, Kemertelidze E, Balansard G (2002) In vitro activity of hederacolchisid A1 compared with other saponins from Hedera colchica against proliferation of human carcinoma and melanoma cells. Planta Med 68:672–675
8. Biersack B, Schobert R (2012) Indole compounds against breast cancer: recent developments. Curr Drug Targets 13:1705–1719
9. Bishayee A (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2:409–418
10. Bishayee A, Ahmed S, Brankov N, Perloff M (2011) Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front Biosci 16:980–996
11. Bishayee A, Thoppil RJ, Waghray A, Kruse JA, Novotny NA, Darvesh AS (2012) Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance. Curr Cancer Drug Targets 12:1191–1232
12. Bishayee A, Mandal A, Thoppil RJ, Darvesh AS, Bhatia D (2013) Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer. Int J Cancer 133:1054–1064
13. Bode AM, Dong Z (2009) Epigallocatechin 3-gallate and green tea catechins: united they work, divided they fail. Cancer Prev Res 2:514–517
14. Bozovic-Spasojevic I, Azambuja E, McCaskill-Stevens W, Dinh P, Cardoso F (2012) Chemoprevention for breast cancer. Cancer Treat Rev 38:329–339
15. Campeau PM, Foulkes WD, Tischkowitz MD (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124:31–42
16. Cazzaniga M, Bonanni B (2012) Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol 2012:985620
17. Chakravarti B, Maurya R, Siddiqui JA, Bid HK, Rajendran SM, Yadav PP, Konwar R (2012) In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid. J Ethnopharmacol 142:72–79
18. Chu R, Zhao X, Griffin C, Staub RE, Shoemaker M, Climent J, Leitman D, Cohen I, Shtivelman E, Fong S (2010) Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid. Int J Cancer 127:1209–1219
19. Corea G, Fattorusso E, Lanzotti V, Di Meglio P, Maffia P, Grassia G, Ialenti A, Ianaro A (2005) Discovery and biological evaluation of the novel naturally occurring diterpene pepluanone as antiinflammatory agent. J Med Chem 48:7055–7062
20. Corea G, Di Pietro A, Dumontet C, Fattorusso E, Lanzotti V (2009) Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy. Phytochem Rev 8:431–447
21. Costa I, Solanas M, Escrich E (2002) Histopathological characterization of mammary neoplastic lesions induced with 7,12-dimethylbenz(a)anthracene in the rat: a comparative analysis with human breast tumors. Arch Pathol Lab Med 126:915–927
22. Council of Scientific and Industrial Research (1972) The wealth of India. A dictionary of Indian raw materials and industrial products. Raw materials, vol 9. Rh-So, Council of Scientific and Industrial Research, New Delhi
23. Crowell PL (1997) Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat 46:191–197
24. Crujeiras AB, Díaz-Lagares A, Carreira MC, Amil M, Casanueva FF (2013) Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res 47:243–256
25. Curigliano G, Goldhirsch A (2011) The triple-negative subtype: new ideas for the poorest prognosis breast cancer. J Natl Cancer Inst 43:108–110
26. Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, Dunn B, Forbes JF, Glaus A, Howell A, von Minckwitz G, Vogel V, Zwierzina H (2011) Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 12:496–503
27. de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47:51–59
28. de Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris GL, Chin M, Krauth M, Lambers Heerspink HJ, Meyer CJ, McMurray JJ, Parving HH, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM (2013) Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON). Am J Nephrol 37:212–222
29. Deng Y, Jiang TY, Sheng S, Tianasoa-Ramamonjy M, Snyder JK (1999) Remangilones A–C, new cytotoxic triterpenes from Physena madagascariensis. J Nat Prod 62:471–476
30. Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV (2009) CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 63:681–689
31. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urban M, Sarek J (2006) Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep 23:394–411
32. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J et al (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 15:R92
33. Efferth T, Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Target 12:122–132
34. El-Alfy TS, Ezzat SM, Hegazy AK, Amer AM, Kamel GM (2011) Isolation of biologically active constituents from Moringa peregrina (Forssk.) Fiori. (family: Moringaceae) growing in Egypt. Pharmacogn Mag 7:109–115
35. Files JA, Stan DL, Allen SV, Pruthi S (2012) Chemoprevention of breast cancer. Womens Health 8:635–646
36. Fukumura M, Ando H, Hirai Y, Toriizuka K, Ida Y, Kuchino Y (2009) Achyranthoside H methyl ester, a novel oleanolic acid saponin derivative from Achyranthes fauriei roots, induces apoptosis in human breast cancer MCF-7 and MDA-MB-453 cells via a caspase activation pathway. J Nat Med 63:181–188
37. González-Vallinas M, González-Castejón M, Rodríguez-Casado A, Ramírez de Molina A (2013) Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev 71:585–599
38. Gould MN (1997) Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 105:977–979
39. Gu G, Barone I, Gelsomino L, Giordano C, Bonofiglio D, Statti G, Menichini F, Catalano S, Andò S (2012) Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation. J Cell Physiol 227:3363–3372
40. Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O (2010) Cancer prevention with natural compounds. Semin Oncol 37:258–281
41. Hao J, Liu J, Wen X, Sun H (2013) Synthesis and cytotoxicity evaluation of oleanolic acid derivatives. Bioorg Med Chem Lett 23:2074–2077
42. Harlev E, Nevo E, Solowey E, Bishayee A (2013) Cancer preventive and curative attributes of plants of the Cactaceae family: a review. Planta Med 79:713–722
43. He X, Liu RH (2007) Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple’s anticancer activity. J Agric Food Chem 55:4366–4370
44. Honda T, Janosik T, Honda Y, Han J, Liby KT, Williams CR, Couch RD, Anderson AC, Sporn MB, Gribble GW (2004) Design, synthesis and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid for the isolation of the protein targets. J Med Chem 47:4923–4932
45. Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ (2012) A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res 18:3396–3406
46. Hsu HF, Houng JY, Chang CL, Wu CC, Chang FR, Wu YC (2005) Antioxidant activity, and DNA information of Glossogyne tenuifolia. J Agric Food Chem 53:6117–6125
47. Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC (2005) Synthetic triterpenoids co-operate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res 65:4799–4808
48. Jeong DW, Kim YH, Kim HH, Ji HY, Yoo SD, Choi WR, Lee SM, Han CK, Lee HS (2007) Dose-linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats. Biopharm Drug Dispos 28:51–57
49. Jia Y, Lu Y, Wu K, Lin Q, Shen W, Zhu M, Huang S, Chen J (2013) Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol 37:197–206
50. Jordan VC (2007) Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat Rev Cancer 7:46–53
51. Kado K, Forsyth A, Patel PR, Schwartz JA (2012) Dietary supplements and natural products in breast cancer trials. Front Biosci 4:546–567
52. Kang X, Hu J, Gao Z, Ju Y, Xu C (2012) Synthesis, anti-proliferative and proapoptotic activity of novel oleanolic acid azaheterocyclic derivatives. Med Chem Commun 3:1245–1249
53. Khan SI, Zhao J, Khan IA, Walker LA, Dasmahapatra AK (2011) Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod Biol Endocrinol 9:91
54. Kim EH, Deng CX, Sporn MB, Liby KT (2011) CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells. Cancer Prev Res 4:425–434
55. Kim EH, Deng C, Sporn MB, Royce DB, Risingsong R, Williams CR, Liby KT (2012) CDDO-methyl ester delays breast cancer development in Brca1-mutated mice. Cancer Prev Res 5:89–97
56. Kirtikar KR, Basu BD (1980) Indian medicinal plants, 2nd edn. Bishen Singh Mahendra Pal Singh, Dehra Dun
57. Konopleva M, Zhang W, Shi YX, McQueen T, Tsao T, Abdelrahim M, Munsell MF, Johansen M, Yu D, Madden T, Safe SH, Hung MC, Andreeff (2006) Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-over expressing breast cancer cells. Mol Cancer Ther 5:317–328
58. Kuttan G, Pratheeshkumar P, Manu KA, Kuttan R (2011) Inhibition of tumor progression by naturally occurring terpenoids. Pharm Biol 49:995–1007
59. Lanzotti V, Termolino P, Dolci M, Curir P (2012) Paviosides A–H, eight new oleane type saponins from Aesculus pavia with cytotoxic activity. Bioorg Med Chem 20:3280–3286
60. Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M (2003) Activation of peroxisome proliferators-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxoleana-1,9-dien-28oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 63:5926–5939
61. Laszczyk MN (2009) Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75:1549–1560
62. Liby KT, Sporn MB (2012) Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 64:972–1003
63. Liby KT, Yore MM, Sporn MB (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7:357–369
64. Liby K, Risingsong R, Royce DB, Williams CR, Yore MM, Honda T, Gribble GW, Lamph WW, Vannini N, Sogno I, Albini A, Sporn MB (2008) Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268. Clin Cancer Res 14:4556–4563
65. Lillie SE, Brewer NT, O’Neill SC, Morrill EF, Dees EC, Carey LA, Rimer BK (2007) Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomarkers Prev 16:249–255
66. Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, Schober W, McQueen T, Dietrich M, Madden TL, Andreeff M (2007) The novel triterpenoid C-28 methyl ester of 2-cyano-3,12-dioxolen-1,9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 67:4210–4218
67. Liu RH (2004) Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134:3479S–3485S
68. Liu J (2005) Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol 100:92–94
69. Malejka-Giganti D, Niehans GA, Reichert MA, Bliss RL (2000) Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis. Cancer Lett 160:209–218
70. Mandal A, Bhatia D, Bishayee A (2013a) Simultaneous disruption of estrogen receptor and Wnt/β-catenin signaling is involved in methyl amooranin-mediated chemoprevention of mammary gland tumorigenesis in rats. Mol Cell Biochem 384:239–250
71. Mandal A, Bhatia D, Bishayee A (2013b) Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis. Mol Carcinog (in press)
72. Matysik G, Wójciak-Kosior M, Paduch R (2005) The influence of Calendulae officinalis flos extracts on cell cultures, and the chromatographic analysis of extracts. J Pharm Biomed Anal 38:285–292
73. Mencherini T, Picerno P, Festa M, Russo P, Capasso A, Aquino R (2011) Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii. J Nat Prod 74:2116–2121
74. Miller JA, Thompson PA, Hakim IA, Sherry Chow HH, Thompson CA (2011) d-Limonene: a bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment. Oncol Rev 5:31–42
75. Ovesná Z, Vachálková A, Horváthová K, Tóthová D (2004) Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 51:327–333
76. Park SY, Kolonel LN, Lim U, White KK, Henderson BE, Wilkens LR (2013) Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: the multiethnic cohort study. Int J Cancer 134:1504–1510
77. Patlolla JM, Rao CV (2012) Triterpenoids for cancer prevention and treatment: current status and future prospects. Curr Pharm Biotechnol 13:147–155
78. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG (2011a) Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365:327–336
79. Pergola PE, Krauth M, Huff JW, Ferguson DA, Ruiz S, Meyer CJ, Warnock DG (2011b) Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am J Nephrol 33:469–476
80. Petronelli A, Pannitteri G, Testa U (2009) Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20:880–892
81. Pierobon M, Frankenfeld CL (2013) Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 137:307–314
82. Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Y, Gribble GW, Leesnitzer LM, Stimmel JB, Willson TM, Rosen E, Sporn MB (2003) The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res 9:2798–2806
83. Pollier J, Goossens A (2012) Oleanolic acid. Phytochemistry 77:10–15
84. Pollier J, Moses T, Goossens A (2011) Combinatorial biosynthesis in plants: a (p)review on its potential and future exploitation. Nat Prod Rep 28:1897–1916
85. Prasad GC (1987) Studies on cancer in Ayurveda and its management. J Res Ayurveda Siddha 8:147–167
86. Rabi T (1996) Antitumor activity of amooranin from Amoora rohituka stem bark. Curr Sci 70:80–81
87. Rabi T, Banerjee S (2008) Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells. Mol Carcinog 47:415–423
88. Rabi T, Bishayee A (2009) Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat 115:223–239
89. Rabi T, Gupta S (2008) Dietary terpenoids and prostate cancer chemoprevention. Front Biosci 13:3457–3469
90. Rabi T, Karunagaram D, Nair MK, Bhattathiri VN (2002) Cytotoxic activity of amooranin and its derivatives. Phytother Res 16:S84–S86
91. Rabi T, Ramachandran C, Fonseca HB, Nair RP, Alamo A, Melnick SJ, Escalon E (2003) Novel drug amooranin induces apoptosis through caspase activity in human breast carcinoma cell lines. Breast Cancer Res Treat 80:321–330
92. Rabi T, Wang L, Banerjee S (2007) Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Breast Cancer Res Treat 101:27–36
93. Rabi T, Huwiler A, Zangemeister-Wittke U (2013) AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells. Mol Carcinog (in press)
94. Reuben SC, Gopalan A, Petit DM, Bishayee A (2012) Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol Nutr Food Res 56:14–29
95. Safe SH, Prather PL, Brents LK, Chadalapaka G, Jutooru I (2012) Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs. Anticancer Agents Med Chem 12:1211–1220
96. Setzer WN, Setzer MC (2003) Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev Med Chem 3:540–556
97. Shan JZ, Xuan YY, Ruan SQ, Sun M (2011) Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro. Chin J Integr Med 17:607–611
98. Shanmugam MK, Nguyen AH, Kumar AP, Tan BK, Sethi G (2012) Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer. Cancer Lett 320:158–170
99. Shanmugam MK, Dai X, Kumar AP, Tan BK, Sethi G, Bishayee A (2013) Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol 85:1579–1587
100. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
101. Sinha D, Biswas J, Sung B, Aggarwal BB, Bishayee A (2012) Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr Drug Targets 13:1799–1819
102. Sogno I, Vannini N, Lorusso G, Cammarota R, Noonan DM, Generoso L, Sporn MB, Albini A (2009) Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids. Recent Results Cancer Res 181:209–212
103. Somova LO, Nadar A, Rammanan P, Shode FO (2003) Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 10:115–121
104. Song M, Hang TJ, Wang Y, Jiang L, Wu XL, Zhang Z, Shen J, Zhang Y (2006) Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry. J Pharm Biomed Anal 40:190–196
105. Speranza G, Gutierrez ME, Kummar S, Strong JM, Parker RJ, Collins J, Yu Y, Cao L, Murgo AJ, Doroshow JH, Chen A (2012) Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors. Cancer Chemother Pharmacol 69:431–438
106. Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW (2011) New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod 74:537–545
107. Suh N, Wang Y, Honda T, Gribble GW, Dmitrovsky E, Hickey WF, Maue RA, Place AE, Porter DM, Spinella MJ, Williams CR, Wu G, Dannenberg AJ, Flanders KC, Letterio JJ, Mangelsdorf DJ, Nathan CF, Nguyen L, Porter WW, Ren RF, Roberts AB, Roche NS, Subbaramaiah K, Sporn MB (1999) A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-Inflammatory activity. Cancer Res 59:336–341
108. Sultana N, Ata A (2008) Oleanolic acid and related derivatives as medicinally important compounds. J Enzyme Inhib Med Chem 23:739–756
109. Szakiel A, Ruszkowski D, Janiszowska W (2005) Saponins in Calendula officinalis L.—structure, biosynthesis, transport and biological activity. Phytochem Rev 4:151–158
110. Tang W, Eisenbrand G (1992) Chinese drugs of plant origin. Springer, Berlin
111. Thoppil RJ, Bishayee A (2011) Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J Hepatol 3:228–249
112. Tran K, Risingsong R, Royce D, Williams CR, Sporn MB, Liby K (2012) The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice. Cancer Prev Res 5:726–734
113. Tran K, Risingsong R, Royce DB, Williams CR, Sporn MB, Pioli PA, Gediya LK, Njar VC, Liby KT (2013) The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer. Carcinogenesis 34:199–210
114. Tsao T, Kornblau S, Safe S, Watt JC, Ruvolo V, Chen W, Qiu Y, Coombes KR, Ju Z, Abdelrahim M, Schober W, Ling X, Kardassis D, Meyer C, Schimmer A, Kantarjian H, Andreeff M, Konopleva M (2010) Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia. Cancer Res 70:4949–4960
115. Ulrich-Merzenich G, Zeitler H, Vetter H, Kraft K (2009) Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. Phytomedicine 16:2–16
116. Vadodkar AS, Suman S, Lakshmanaswamy R, Damodaran C (2012) Chemoprevention of breast cancer by dietary compounds. Anticancer Agents Med Chem 12:1185–1202
117. Venugopal R, Liu RH (2012) Phytochemicals in diets for breast cancer prevention: the importance of resveratrol and ursolic acid. Food Sci Hum Wellness 1:1–13
118. Wang X, Ye XL, Liu R, Chen HL, Bai H, Liang X, Zhang XD, Wang Z, Li WL, Hai CX (2010) Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem Biol Interact 184:328–337
119. Withers ST, Keasling JD (2007) Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol 73:980–990
120. Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB (2010) Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins 2:2428–2466
121. Yang H, Dou QP (2010) Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr Drug Targets 11:733–744
122. Yiannakopoulou EC (2014) Effect of green tea catechins on breast carcinogenesis: a systematic review of in vitro and in vivo experimental studies. Eur J Cancer Prev 23:84–89
123. Yin MC, Lin MC, Mong MC, Lin CY (2012) Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J Agric Food Chem 60:7697–7701
124. Yun BS, Ryoo IJ, Lee IK, Park KH, Choung DH, Han KH, Yoo ID (1999) Two bioactive pentacyclic triterpene esters from the root bark of Hibiscus syriacus. J Nat Prod 62:764–766
125. Zhang W, Popovich DG (2009) Chemical and biological characterization of oleanane triterpenoids from soy. Molecules 14:2959–2975
126. Zhang H, Boghigian BA, Armando J, Pfeifer BA (2011) Methods and options for the heterologous production of complex natural products. Nat Prod Rep 28:125–151